Does PEGINTERFERON BETA-1A Cause Therapy cessation? 27 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Therapy cessation have been filed in association with PEGINTERFERON BETA-1A (Plegridy Pen). This represents 0.2% of all adverse event reports for PEGINTERFERON BETA-1A.
27
Reports of Therapy cessation with PEGINTERFERON BETA-1A
0.2%
of all PEGINTERFERON BETA-1A reports
0
Deaths
4
Hospitalizations
How Dangerous Is Therapy cessation From PEGINTERFERON BETA-1A?
Of the 27 reports, 4 (14.8%) required hospitalization.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEGINTERFERON BETA-1A. However, 27 reports have been filed with the FAERS database.
What Other Side Effects Does PEGINTERFERON BETA-1A Cause?
Influenza like illness (1,431)
Injection site erythema (1,041)
Multiple sclerosis relapse (945)
Fatigue (673)
Headache (587)
Pain (580)
Injection site reaction (569)
Device malfunction (567)
Multiple sclerosis (536)
Pyrexia (503)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which PEGINTERFERON BETA-1A Alternatives Have Lower Therapy cessation Risk?
PEGINTERFERON BETA-1A vs PEGINTRON
PEGINTERFERON BETA-1A vs PEGLOTICASE
PEGINTERFERON BETA-1A vs PEGUNIGALSIDASE ALFA-IWXJ
PEGINTERFERON BETA-1A vs PEGVALIASE-PQPZ
PEGINTERFERON BETA-1A vs PEGVISOMANT